These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26897347)

  • 1. Case report: Inadvertent intra-arterial injection during sclerotherapy may not be the disaster you think.
    Thomas P; Martin J; Braithwaite B
    J Vasc Nurs; 2016 Mar; 34(1):12-6. PubMed ID: 26897347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up.
    Moreno-Moraga J; Smarandache A; Pascu ML; Royo J; Trelles MA
    Phlebology; 2014 Dec; 29(10):658-66. PubMed ID: 23989971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulsed-dye laser treatment of leg telangiectasia: with and without simultaneous sclerotherapy.
    Goldman MP; Fitzpatrick RE
    J Dermatol Surg Oncol; 1990 Apr; 16(4):338-44. PubMed ID: 2324370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial injection, a rare but serious complication of sclerotherapy.
    Hafner F; Froehlich H; Gary T; Brodmann M
    Phlebology; 2013 Mar; 28(2):64-73. PubMed ID: 22422795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsed dye laser treatment of telangiectases with and without subtherapeutic sclerotherapy. Clinical and histologic examination in the rabbit ear vein model.
    Goldman MP; Martin DE; Fitzpatrick RE; Ruiz-Esparza J
    J Am Acad Dermatol; 1990 Jul; 23(1):23-30. PubMed ID: 2365873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy.
    Schuller-Petrović S; Pavlović MD; Neuhold N; Brunner F; Wölkart G
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):983-6. PubMed ID: 21740464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison and sequential study of long pulsed Nd:YAG 1,064 nm laser and sclerotherapy in leg telangiectasias treatment.
    Levy JL; Elbahr C; Jouve E; Mordon S
    Lasers Surg Med; 2004; 34(3):273-6. PubMed ID: 15022257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aesthetic treatment of leg veins.
    Vitale-Lewis VA
    Aesthet Surg J; 2008; 28(5):573-83. PubMed ID: 19083582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1% polidocanol.
    Künzlberger B; Pieck C; Altmeyer P; Stücker M
    Dermatol Surg; 2006 Nov; 32(11):1410-3. PubMed ID: 17083597
    [No Abstract]   [Full Text] [Related]  

  • 10. Consensus for sclerotherapy.
    Weiss MA; Hsu JT; Neuhaus I; Sadick NS; Duffy DM
    Dermatol Surg; 2014 Dec; 40(12):1309-18. PubMed ID: 25418805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study between cryo-laser cryo-sclerotherapy and sclerotherapy in the treatment of telangiectasia and reticular veins: A randomized controlled trial.
    Nasser MM; Ghoneim BM; Eldaly W; Elmahdy H
    J Vasc Surg Venous Lymphat Disord; 2024 Jul; 12(4):101874. PubMed ID: 38522666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline.
    Peterson JD; Goldman MP; Weiss RA; Duffy DM; Fabi SG; Weiss MA; Guiha I
    Dermatol Surg; 2012 Aug; 38(8):1322-30. PubMed ID: 22620717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pilot study evaluating the treatment of leg veins with a long pulse ND:YAG laser and sclerotherapy.
    Coles CM; Werner RS; Zelickson BD
    Lasers Surg Med; 2002; 30(2):154-9. PubMed ID: 11870796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical comparison of sclerotherapy versus long-pulsed Nd:YAG laser treatment for lower extremity telangiectases.
    Lupton JR; Alster TS; Romero P
    Dermatol Surg; 2002 Aug; 28(8):694-7. PubMed ID: 12174060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telangiectasias resistant to sclerotherapy are commonly connected to a perforating vessel.
    Schuller-Petrović S; Pavlović MD; Schuller S; Schuller-Lukic B; Adamic M
    Phlebology; 2013 Sep; 28(6):320-3. PubMed ID: 22865418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual complication of facial sclerotherapy.
    Hoffman K
    Dermatol Surg; 2003 Apr; 29(4):423-4. PubMed ID: 12656827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polidocanol (aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias.
    Goldman PM
    J Dermatol Surg Oncol; 1989 Feb; 15(2):204-9. PubMed ID: 2644330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerotherapy for leg telangiectasia--a blinded comparative trial of polidocanol and hypertonic saline.
    McCoy S; Evans A; Spurrier N
    Dermatol Surg; 1999 May; 25(5):381-5; discussion 385-6. PubMed ID: 10469077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
    Rabe E; Schliephake D; Otto J; Breu FX; Pannier F
    Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.